RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:A2AR limits IL-15-induced generation of CD39(+) NK cells with high cytotoxicity.
A2AR limits IL-15-induced generation of CD39(+) NK cells with high cytotoxicity.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
CD39介导的NK细胞活性抑制已被证实,但人类CD39+ NK细胞的特征尚不清楚。我们研究了人循环CD39+ NK细胞的特征。在健康供者中,循环CD39+ NK细胞占总NK细胞的比例相对低于CD39- NK细胞。尽管如此,CD39+ NK细胞中表达CD107a的比例更高。同样,在乙型肝炎病毒患者或肝细胞癌患者中,CD39+ NK细胞中表达CD107a的比例也更高。用NK敏感的K562细胞或白细胞介素(IL)-12/IL-18刺激后,相对于CD39- NK细胞,CD39+ NK细胞表达更高水平的CD107a、IFN-γ和TNF-α。
重要的是,IL-15诱导了CD39+ NK细胞的生成。相反,A2A腺苷受体(A2AR)连接通过抑制IL-15信号传导抑制了CD39+ NK细胞的生成。这些数据首次证明,A2AR拮抗IL-15诱导的人CD39+ NK细胞生成,而CD39+ NK细胞比CD39- NK细胞具有更强的细胞毒性。IL-15诱导的人CD39+ NK细胞可能是基于NK细胞过继转移免疫治疗的更好选择。
CD39-mediated inhibition of natural killer (NK) cell activity has been demonstrated, but the characteristics of CD39 + NK cells in humans are not known.
We investigated the characteristics of human circulating CD39 + NK cells. In healthy donors, the proportion of circulating CD39 + NK cells in total NK cells was relatively low compared with that of CD39 - NK cells. Nonetheless, a higher proportion of CD39 + NK cells expressed CD107a.
Similarly, a higher proportion of CD39 + NK cells expressed CD107a in patients with hepatitis B virus or patients with hepatocellular carcinoma. Stimulation with NK-sensitive K562 cells or interleukin (IL)-12/IL-18 activated CD39 + NK cells to express higher levels of CD107a, IFN-γ and TNF-α, relative to CD39 - NK cells.
Importantly, IL-15 induced the generation of CD39 + NK cells. In contrast, A2A adenosine receptor (A2AR) ligation suppressed the generation of CD39 + NK cells by inhibiting IL-15 signaling. These data for the first time demonstrated that A2AR counteracts IL-15-induced generation of human CD39 + NK cells, which have a stronger cytotoxicity than CD39 - NK cells. IL-15-induced human CD39 + NK cells might be better choice for immunotherapy based on adoptive transfer of NK cells.
MEMBER ACCOUNT
登录成功会直接打开下一页。